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What Determines the Shape of an
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Background. EQ-5D-3L index scores in patient and gen-
eral populations typically have a nonnormal distribution,
divided into 2 distinct groups. It is important to under-
stand to what extent this is determined by the way that
the EQ-5D-3L index is constructed rather than by the true
distribution of ill health. Objective. This paper examines
the determinants of the ‘‘2 groups’’ distribution pattern
and the extent to which this pattern is attributable either
to the EQ-5D-3L classification system used to create
health state profiles or to the weights applied to profiles.
Methods. Data from the English NHS PROMs program (hip
and knee replacements and varicose vein and hernia
repairs) and from a study of 2 chronic conditions (asthma
and angina) were used to compare the distributions of EQ-
5D-3L index scores with distributions from which weights
have been stripped; profile data decomposed into their
constituent dimensions and levels; a condition-specific
index; and using weights from different countries, based on
both time tradeoff and visual analogue scale. Results. The
EQ-5D-3L classification system generates differences
between patients with the same condition in respect of
dimensions that are mainly observed at level 2 or 3. The
weights commonly used to calculate the index exacerbate
this grouping by placing a larger weight on level 3 observa-
tions, generating a noticeable gap in index scores between
the groups. Conclusions. Analyzing EQ-5D profile data
enables a better understanding of the resulting distribution
of EQ-5D scores. The distinctive shape observed for these
distributions is the result of both the classification system
and the weights applied to it. Key words: EQ-5D; health-
related quality of life; health state preferences; utilities;
valuations. (Med Decis Making 2016;36:941–951)
The EQ-5D is internationally one of the mostwidely used health-related quality-of-life instruments.
1 It is therefore very important to
obtain a good understanding of the characteristics
of EQ-5D data. Many studies of the original 3-level
version of the EQ-5D (now known as the EQ-5D-3L)
have found that its index scores typically have a
nonnormal distribution divided into 2 distinct
groups. (This is often described as ‘‘bimodal,’’ but
we will argue that this label is misleading.) This
phenomenon has been found in both patient and
general populations, for many conditions, and
using different country-specific value sets. In exam-
ining the distribution of health states within a par-
ticular population, it is useful to know to what
extent its shape is determined by the way that the
EQ-5D-3L index is constructed rather than by the
true distribution of ill health. In addition, the index
is constructed from 2 separate elements—a classifi-
cation system used to create health state profiles
and a set of weights applied to profiles—and it is
useful to know the relative importance of these fac-
tors in shaping health state distributions.
This paper examines the determinants of the
shape of EQ-5D-3L index score distributions, in par-
ticular the origins of the ‘‘2 groups’’ distribution.
We analyze data from patients undergoing elective
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surgery (hip and knee replacements and varicose
vein and hernia repairs) in the UK National Health
Service (NHS) and from primary care patients in a
study of 2 chronic conditions (asthma and angina).
The distributions are compared with those of index
scores from which weights have been stripped, and
profile data are decomposed into their constituent
dimensions and levels to see how they influence
those distributions. Distributions that arise from
applying different sources of weights (value sets),
including those from countries other than the United
Kingdom, are demonstrated. They are also compared
with the distributions of condition-specific indexes
assessed for the same patients. We conclude by sug-
gesting practical ways in which researchers could
analyze EQ-5D index data to obtain richer results
than are conventionally reported.
BACKGROUND
The EQ-5D is used widely in economic analyses
and population health surveys and for routine
assessment of patients’ health: for example, the
Patient Reported Outcome Measures (PROMs) pro-
gram for the NHS.2 The EQ-5D-3L instrument com-
prises 2 self-report elements: The first is the EQ-5D
self-classifier, where respondents tick boxes to indi-
cate which of 3 levels of problems (no, some,
extreme) they have on each of 5 dimensions (mobi-
lity [MO], self-care [SC], usual activities [UA], pain
and discomfort [PD], and anxiety and depression
[AD]) to create a health profile. The second element
is a visual analogue scale, the EQ-VAS, on which
respondents rate their overall health from 0 (worst
health imaginable) to 100 (best health imaginable).
The profile and EQ-VAS both provide valuable
information about patients’ views of their own
health, and either can form the analytical focus.
Profile data can be analyzed in different ways (e.g.,
a Health Profile Grid and a Paretian Classification of
Health Change2), but by far the most common way
is to use index scores to summarize the data. These
scores provide, for each of the 243 (=35) possible
states described by the EQ-5D-3L, a value on a scale
anchored at 1 (full health) and 0 (a state as bad as
being dead), with values less than 0 indicating
states worse than being dead. Typically, these
values are obtained for a subset of states from gen-
eral public surveys, using stated preference meth-
ods to ascertain their views about how good or
bad the states are. These sample data are used to
model values for all states. The resulting value sets,
sometimes called tariffs, result from and are influ-
enced by factors including choices about whose
values are relevant (e.g., the general public or
patient populations), the methods used to elicit pre-
ferences (e.g., time tradeoff, visual analogue scale,
or standard gamble), and how the data are modeled.
There are clear normative grounds for using
index scores to summarize profile data where the
purpose is to estimate quality-adjusted life-year
gains for economic evaluation. For example, it is
often argued that for decisions in the UK’s tax-
funded NHS, the relevant values are those of the
general public, as taxpayers and potential users of
the service. However, index scores are also widely
used in other applications, where that rationale
may not apply. For example, the Health Survey for
England3 reports all EQ-5D data as index scores,
even though they are intended as descriptive rather
than evaluative. This is probably because single
numbers are easier to analyze and report than are
profiles comprising multiple dimensions. This prac-
tice may also result from a mistaken belief that
index scores are like the scoring systems used in
condition-specific instruments, which are usually
developed as an integral part of the instrument.
Some important concerns have been raised about
the use of index scores to summarize EQ-5D pro-
files. This introduces an exogenous source of var-
iance, which can bias statistical inference.4,5 For
example, conclusions about whether there are sta-
tistically significant differences in the health of 2
regions, or over time, or between 2 arms of a clinical
trial, may be influenced by which value set is used.
More generally, there is no such thing as a neutral
value set. Any weighting of EQ-5D profile data
exerts an influence on results. This point is not
peculiar to the EQ-5D; it applies equally to other
health measures’ scoring systems, both generic and
condition specific, including measures that simply
sum ranked responses.
Because the EQ-5D is such a widely used instru-
ment and because an index is so often used to sum-
marize it, understanding the characteristics of the
index is very important. An issue that has been
widely identified as problematic is that the distribu-
tion of EQ-5D-3L scores is nonnormal, having what
is often labeled a bimodal shape. The main concern
has been about possible estimation problems if this
shape results in a nonnormal distribution of resi-
duals when the EQ-5D index is the dependent vari-
able in regression analyses.
A further problem is that a bimodal distribution
might imply that there are actually 2 separable
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patient populations that should be analyzed sepa-
rately. It might be that many patient populations
comprise distinct groups, and the EQ-5D-3L is capa-
ble of picking out 2 of them. Alternatively, the EQ-
5D profile might divide patients into groups even
though they are from a common distribution, or the
weighting of EQ-5D profiles might have that result.
Knowing which of these is the source of the
observed distribution pattern is crucial to its proper
analysis and interpretation.
Studies that have identified this issue, reviewed
below, often suggest that the score distributions are
bimodal or trimodal, but those labels are mislead-
ing. A better description is that the distributions
identify 2 groups, with an identifiable gap in
scores between them. We will refer to these as the
‘‘high cluster’’ and the ‘‘low cluster.’’ The label tri-
modal has been used where there are many obser-
vations of people who have no problems according
to the EQ-5D classification, forming a third group,
again with a gap from the high cluster. The large
gap between no problems (11111 = 1) and the next
best health state (11211 = 0.883 using the weights
most widely used in the UK6) is important, but the
reason why a single score ‘‘group’’ at 1 exists is
obvious, and its mode is trivially determined. The
interesting questions concern the other 2 groups
and the gap between them, which has been identi-
fied as being around 0.57 or 0.45.8,9 The reason
why bimodal is a misleading description for this
phenomenon is that the modes of the 2 groups are
not their most interesting feature; the groups do
not always have a single local mode; and in prac-
tice these modes are never actually identified,
reported, or analyzed.
This feature of EQ-5D-3L index distributions has
been reported in studies covering a diverse range of
conditions. There have been many studies in arthri-
tis,7,10–20 rheumatic disease,21,22 orthopedic condi-
tions and treatments including herniated lumbar
disc,23 common spinal conditions for which surgery is
indicated,24 total knee replacement,25,26 lumbar spinal
stenosis,27 all elective orthopedic operations,28,29 and
hip arthroplasty.30 Studies of other conditions and
populations include accident victims with life-threa-
tening injuries,10 breast cancer,31 chronically ill
patients undergoing hemodialysis,32 lower back pain,
chronic obstructive pulmonary disease, end-stage
renal disease,10 irritable bowel syndrome, leg ulcer
and osteoporosis,8,9 menopausal women and healthy
older women,8 pregnant women with chronic energy
deficiency,33 HIV,34 postmenopausal women,35 multi-
ple myeloma and non-Hodgkin’s lymphoma,7 asthma,
chest pain, clodronate, hormone replacement therapy,
leg reconstruction and varicose veins,9 and multiple
sclerosis.36
It is often alleged that the gap arises because the
decrement in the index between levels 2 and 3 is rela-
tively large compared with that between levels 1 and
2.11 More specifically, the so-called ‘‘N3’’ term6 used
to calculate the index in the UK and elsewhere has
been implicated.8,9,21,31 This gives a large decrement
to the index if any dimension has a level 3 state.
The presence or absence of a level 3 observation
does, in practice, place the UK index score above or
below 0.5. If there is any level 3 in a profile, the
score is at most (1 2 [0.081 + 0.269]) = 0.650. The
maximum score that any profile can have with a
level 3 in a particular dimension is therefore 0.336
(MO), 0.436 (SC), 0.556 (UA), 0.264 (PD), or 0.414
(AD). The smallest level 2 increment for dimensions
other than UA is 0.069 (MO). Therefore, only 1 of
the 211 (= 35 – 25) profiles that include a level 3
observation also has a score above 0.5, namely
11311. This is an unusual profile that is very rarely
encountered in practice. Conversely, all 32 profiles
that do not include a level 3 observation have a
score above 0.5.
Related to this is evidence that in mapping
between the EQ-5D-3L and other health indexes,
the EQ-5D-3L may overestimate the scores for more
severe health states. One study37 hypothesized that
predictions are poor for more severe states, defined
as index lower than 0.5, because they all have at
least 1 dimension at the most severe level and the
UK EQ-5D-3L model uses the N3 term. The impor-
tance of this term was tested by reestimating the UK
model without it, using the same data and methods
as the original.6 Although the predictions for more
severe health states were better, they still appeared
to be overestimated.
To test the hypothesis that N3 in itself does not
generate a bimodal distribution, authors of another
study7 generated a random set of EQ-5D cases with
an equal distribution of answers across the dimen-
sions. The authors claimed that the resulting index
scores were normally distributed, although it is
more accurate to say that the distribution did not
have the 2-groups-and-gap shape, suggesting that
N3 is not the sole cause of that shape. The authors
concluded that although N3 is a factor in the bimo-
dal distribution and overestimation in mapping
states whose scores are less than 0.5, these also
arise from the fact that fewer responses are observed
at level 3 than at level 1 or 2, and only a few states
are observed.
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Some studies have examined whether the exis-
tence of 2 groups is an artefact or whether, in some
cases or in some way, it does identify different
patient groups. One group of authors asserted27,28
‘‘We strongly believe that it is the structure of the
instrument that causes this phenomenon rather
than the fact that it appears to highlight 2 sub-
groups of patients.’’28(p88) One study36 examined
this by seeking external validation of the groups
identified by the EQ-5D distribution. In mapping a
condition-specific measure (i.e., the MSWS-12) to
the EQ-5D-3L, the authors calculated median
MSWS-12 scores for 2 groups defined by a cut-
point, which was the EQ-5D-3L score closest to 0.5.
DATA AND METHODS
We explored the issues using both simulated and
real data. First, an artificial data set was created,
comprising 1 observation of each possible health
state described by the EQ-5D-3L, from 11111 (no
problems in any dimension) to 33333 (severe prob-
lems on all dimensions). This is equivalent to a data
set consisting of random health states that have an
equal probability of occurring. Each state was
assigned 2 index scores, one using the UK weights
and the other using an ‘‘equally weighted’’ scoring
system, calculated by summing the level numbers
(1, 2, or 3) over all dimensions, producing a number
from 5 for the best health state to 15 for the worst
health state. The equal weighting index was then
converted so that it had the same range (20.594 to
1) as the UK value set, using a linear transformation.
The 2 resulting distributions were smoothed using
identical kernel density estimation functions.
Second, we analyzed real patient data on 4
elective surgical procedures (hip and knee replace-
ments and varicose vein and groin hernia repairs),
which were collected by the English NHS PROMs
program2 from April 2009 to February 2011. This
program collects data before and after surgery.
Questionnaires are completed by patients mainly in
preoperative clinics, which are then followed up by
postal questionnaires 3 months (varicose vein and
hernia) or 6 months (hip and knee) afterward. The
aim is to collect data from every NHS patient in
England, but in practice data are not always com-
pleted. We report analyses only from the preopera-
tive data. We also analyzed old primary care data
on angina and asthma patients collected as part of
a trial38 in which patients identified as having
those conditions completed a postal questionnaire
including the EQ-5D on 3 occasions. We report
analyses of the data from the first survey. Rather
than report all of our analyses for every data set, for
some of them we focus on hip replacement data as
an example.
The analysis consisted mainly of comparing
index distributions using different ways of classify-
ing and weighting profiles. We explored 2 different
ways of classifying profiles into the 2 groups: divid-
ing profiles into those above and below the EQ-5D-
3L index score 0.5; and using a clustering tech-
nique, specifically the kmeans clustering procedure.
This partitions observations into one of a prede-
fined number of clusters, in this case 2, such that
the within-cluster sum of squares is minimized.
Each observation is assigned to the cluster with the
mean closest to its own score.
We decomposed the profile data into its dimen-
sions and levels to analyze whether the frequencies
with which different combinations of these are
found in patient populations could account for the
observed clustering. We examined whether the EQ-
5D-3L clusters were also identified by a different,
condition-specific health measure. We compared
the prevalence of clustering based on different
country-specific value sets.
RESULTS
Inspecting the shape of frequency distributions
for health states with and without index weighting
demonstrates the effect of index weighting. Figure 1
shows smoothed, UK-weighted, EQ-5D-3L index
score distributions for the artificial data set described
above. This might suggest that equally weighted data
are naturally normally distributed, whereas UK
weighted data are naturally skewed and bimodal.
But is this purely a product of index weighting, or
are other factors involved?
We explored this using the data on hip and knee
replacements, varicose vein and groin hernia
repairs, and angina and asthma patients. Figure 2
shows the index score distributions for patients
prior to hip replacement surgery, which clearly
exhibits a 2-groups-with-gaps pattern. (Ignore for
now the distinction between low and high clusters.)
Because it is less important for our purposes, we
will disregard the third group, comprising all
patients who reported no problems on any dimen-
sion. Patients undergoing varicose vein surgery
have very different health characteristics compared
with hip replacement patients. However, Figure 3
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demonstrates that the distribution of their index
scores also has the 2-groups-with-gaps pattern.
We first identified more rigorously the 2 groups
suggested by the histograms. Inspection of the hip
replacement histogram suggests that they could be
defined as being above or below 0.5. The kmeans
procedure identifies a different divider, lying
between 0.313 and 0.329. However, the 2 methods
classify only 1180 of 99,447 observations differ-
ently. In Figures 2 and 3, the high and low clusters
are those identified by the kmeans procedure.
The index scores shown in these distributions
result from applying a specific set of weights to pro-
files. We next examined the possibility that the pro-
files themselves are a source of the observed
clustering. If we look first at the different dimen-
sions separately, Table 1 shows the percentage of
responses in each level of each dimension. This
suggests that responses do not vary across all 3
levels in any dimensions; that is, either 1 or 2 levels
dominate. There is very little difference between
patients about to receive hip surgery with respect to
MO; they almost always record level 2 and very
rarely record level 3. (One reason for this is that the
EQ-5D-3L label for level 3 is ‘‘confined to bed,’’ so
even patients with very severe mobility limitations
will not choose level 3.39) In each of the other
dimensions, 2 levels dominate. For SC and AD
these are levels 1 and 2, and for UA and PD they are
levels 2 and 3. In each case, the less severe of the 2
levels has the largest numbers.
We can therefore rule out differences in mobility
as a cause of the 2 groups observed in these data.
We next examine the distribution of profiles to see
whether the other dimensions are individually or in
combination the cause, as in Table 2, which shows
only the most frequently observed profiles. Between
them, these 12 profiles account for 80% of all pro-
files in this data set. The 4 within the high cluster
account for 81% of profiles in that cluster, and the 8
Figure 1 Distribution of equally weighted and UK-weighted
scores for all 243 EQ-5D profiles in the EQ-5D descriptive system.
Equal weight: mean 0.203, median 0.203, mode 0.203, standard
deviation 0.292, skewness 0.000, kurtosis 2.700. Normality con-
firmed by skewness/kurtosis tests. UK weights: mean 0.137,
median 0.109, mode 0.107, standard deviation 0.311, skewness
0.437, kurtosis 2.95. Local minimum 0.559; local mode 0.700.
Nonnormality confirmed by skewness/kurtosis tests.
Figure 2 Distribution of presurgery EQ-5D index scores for hip
replacement patients, using UK-weighted index.
Figure 3 Distribution of presurgery EQ-5D index scores for vari-
cose vein patients, using UK-weighted index.
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within the low cluster account for 79% of profiles
in that cluster.
All 12 profiles have, as suggested by the earlier
figures, MO = 2. The 4 main profiles in the high
cluster all have UA = 2 and PD = 2. They are distin-
guished only by whether they have SC = 1 or 2 and
AD = 1 or 2. The 8 profiles in the low cluster also
appear in the 4 high-cluster profiles, but with PD =
3, UA = 3, or both.
The implication is that the difference between
the 2 groups is simply in the dimensions of PD and
UA—the low cluster includes people who experi-
ence more pain and discomfort and have more
restrictions on their usual activities than those in
the high cluster. There is a complicating factor,
because the difference within these dimensions is
between levels 2 and 3 rather than 1 and 2, and the
presence of one or more level 3 gives additional
decrements in scores within the UK value set. This
is both because the differences between levels 2 and
3 in each dimension are greater than those between
levels 1 and 2 and also because of the N3 term. The
question remains whether it is the difference
between the dimensions alone that generates the
clusters or the fact that the low score cluster has
more level 3 observations.
For varicose vein patients, the difference between
the 2 groups is as clear. Almost all in both groups
report SC = 1. Almost all patients in the high cluster
report PD = 2 and do not have a level 3 in any
dimension. Almost all of those in the low cluster
report PD = 3, and a few report a level 3 in dimen-
sions other than SC. Again, the fact that the differ-
ence is in level 3 is a complication. Table 3 shows
the most frequent profiles, excluding 11111. One
dominant profile, 11121, has nearly half of the high-
cluster profiles, but otherwise there is much greater
variation in frequently observed profiles within
both high and low clusters, with 95% of high-clus-
ter profiles covered by 9 profiles and 90% of low-
cluster profiles covered by 24 profiles.
We have therefore demonstrated that the classifi-
cation system itself can generate clusters defined by
dimensions and levels according to numbers of
Table 1 Percentage of Responses in Different Dimensions and Levels of the EQ-5D for Presurgery Hip
Replacement Patients
Level Mobility Self-Care Usual Activities Pain and Discomfort Anxiety and Depression
1 6.16% 42.94% 6.02% 1.00% 55.19%
2 93.21% 55.39% 72.74% 55.86% 39.07%
3 0.63% 1.67% 21.24% 43.15% 5.75%
Table 2 Distributions of the EQ-5D Profile for Presurgery Hip Replacement Patients within High and Low
Clusters
Within Cluster Overall
Profile Index Number % Cumulative % % Cumulative %
High cluster
21221 0.691 15,579 30.42 30.42 15.67 15.67
22221 0.587 11,631 22.71 53.13 11.70 27.37
22222 0.516 8041 15.70 68.83 8.09 35.46
21222 0.620 6105 11.92 80.76 6.14 41.60
Low cluster
22232 20.016 9216 19.11 19.11 9.27 50.87
22231 0.055 7315 15.17 34.27 7.36 58.23
22332 20.074 6515 13.51 47.78 6.55 64.78
21231 0.159 4801 9.95 57.73 4.83 69.61
22331 20.003 3453 7.16 64.89 3.47 73.08
21232 0.088 3017 6.25 71.14 3.03 76.11
22333 20.239 2057 4.26 75.41 2.07 78.18
22322 0.189 1660 3.44 78.85 1.67 79.85
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observations, at least for the data that we have ana-
lyzed. The next step is to investigate whether this is
sufficient by itself to generate clusters defined by
index scores and whether the relative size of the
weights given to different levels and dimensions
contributes to this.
One way to examine this is to change the
weights and see whether the clustering apparent
when the UK weights are used remains. For exam-
ple, we could apply to the profile data different
weights to those in the UK value set and see
whether the same or different clusters are
generated. Ideally, this would entirely remove the
effect of weighting, but there is of course no such
thing as a truly unweighted score and, as noted
earlier, there is no neutral set of weights that can
be used for this purpose. In the analysis of Figure
1, we applied equal weights for levels and dimen-
sions to an artificial data set that by construction
contained no clusters in levels and dimensions,
demonstrating that a bimodal distribution of the
UK-weighted index (in this case, bimodal is a
better term than clusters) can arise without any
such clusters. However, this process oversmooths
Table 3 Distributions of the EQ-5D Profile for Varicose Vein Repair Patients within High and Low Clusters
Within Cluster Overall
Profile Index Number % Cumulative % % Cumulative %
High cluster
11121 0.796 9038 48.96 48.96 43.57 43.57
11122 0.725 1953 10.58 59.54 9.41 52.98
21221 0.691 1595 8.64 68.18 7.69 60.67
11221 0.760 1404 7.61 75.79 6.77 67.44
21121 0.727 1081 5.86 81.64 5.21 72.65
21222 0.620 967 5.24 86.88 4.66 77.31
11112 0.848 658 3.56 90.44 3.17 80.48
11222 0.689 572 3.10 93.54 2.76 83.24
21122 0.656 353 1.91 95.46 1.70 84.94
Low cluster
21232 0.088 330 14.44 14.44 1.59 86.53
21231 0.159 295 12.91 27.35 1.42 87.95
11131 0.264 174 7.61 34.97 0.84 88.79
22232 20.016 125 5.47 40.44 0.60 89.40
11123 0.291 107 4.68 45.12 0.52 89.91
21223 0.186 105 4.60 49.72 0.51 90.42
21131 0.195 101 4.42 54.14 0.49 90.90
11231 0.228 91 3.98 58.12 0.44 91.34
21233 20.077 83 3.63 61.75 0.40 91.74
22231 0.055 79 3.46 65.21 0.38 92.12
22233 20.181 56 2.45 67.66 0.27 92.39
11232 0.157 53 2.32 69.98 0.26 92.65
11132 0.193 50 2.19 72.17 0.24 92.89
21132 0.124 42 1.84 74.00 0.20 93.09
22332 20.074 41 1.79 75.80 0.20 93.29
11113 0.414 39 1.71 77.51 0.19 93.48
21321 0.364 37 1.62 79.12 0.18 93.66
11223 0.255 36 1.58 80.70 0.17 93.83
21332 0.030 34 1.49 82.19 0.16 93.99
22333 20.239 32 1.40 83.59 0.15 94.15
22223 0.082 30 1.31 84.90 0.14 94.29
21123 0.222 29 1.27 86.17 0.14 94.43
21331 0.101 27 1.18 87.35 0.13 94.56
21333 20.135 26 1.14 88.49 0.13 94.69
21322 0.293 25 1.09 89.58 0.12 94.81
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the data into 11 categories that contain very differ-
ent health profiles, giving a very weak test of the
effect of specific weights on real data that contain
real profile clusters. For example, applying this to
hip replacement and varicose vein repair data gen-
erates distributions that have a single mode but are
skewed; when ordered from worst to best, they are
skewed positively for hips and negatively for vari-
cose veins. A better alternative is to convert the set
of weights into ranks. This retains the level of
detail, in that every profile has an individual
score, but removes the impact of size differences in
the relative weighting of levels and dimensions,
including removing the level 3 factor.
The result of this is shown in Figure 4 for hip
replacement patients. In this figure, the ranks are
transformed so that they have the same scale as the
UK EQ-5D-3L index—this is simply to make direct
visual comparisons easier and has no impact on the
results. The division into 2 groups is less obvious,
because of the wider spread of the data in the low
cluster, but it does exist. The same result is
obtained when the same procedure is applied to the
varicose vein data.
A possible conclusion is therefore as follows:
(a) The division into 2 groups can result from differ-
ences between clusters of patients identified by
the EQ-5D-3L classification system in key dimen-
sions of health.
(b) This distribution will be reinforced by the weight-
ing system, which generates the large gap between
the 2 groups in index scores.
A final question is whether the 2-group distribu-
tion reflects true differences in the health of a
sample or is an artefact of the classification system.
It is not possible to answer that question directly,
but it is possible to explore it using additional
data. The NHS PROMs program data also include
condition-specific health state instruments—for hip
replacements, the widely used and well-validated
Oxford Hip Score (OHS).40 The OHS is calculated
from a 12-item questionnaire, each item having 5
possible response categories ranked from 0 (no
problems) to 4 (most severe in that item). The score
is obtained by summing the ranks over all items and
therefore takes 1 of 49 values from 0 (most severe in
every item) to 48 (no problems). Is the 2-group dis-
tribution apparent in OHS data?
Figure 5 shows a density distribution for the
PROMs OHS data, which does not exhibit any clus-
tering. It is unimodal with a positive skew. If the
OHS is a more accurate measure of hip patients’
health status than the EQ-5D, this would imply that
the EQ-5D clusters are indeed an artefact. However,
if the OHS density distributions are calculated sepa-
rately for the 2 EQ-5D clusters a different picture
emerges, as shown in Figure 6 by a combined plot
of these 2 distributions. Both distributions are
unimodal; the high EQ-5D cluster group also has a
positively skewed OHS distribution, but the low
cluster has a symmetrical distribution. The overall
Figure 4 Distribution of presurgery EQ-5D rank scores for hip
replacement patients by cluster, using transformed ranking.
Figure 5 Distribution of presurgery Oxford Hip Score for hip
replacement patients.
PARKIN AND OTHERS
948  MEDICAL DECISION MAKING/NOVEMBER 2016
OHS distribution may therefore be the sum of the
overlapping distributions of 2 groups, 1 of which
has worse health than the other. A Mann-Whitney
test of the null hypothesis that the observations in
the 2 clusters are drawn from the same distribution
is rejected (z = 2211.927, P \ 0.00005). This evi-
dence is therefore consistent with the possibility
that the EQ-5D clusters identify genuinely separate
groups of hip patients according to the severity of
their condition.
A conclusion is that better descriptions of EQ-
5D-3L index distributions are required, which take
account of what appears to be a natural tendency to
form a 2-groups-and-gap pattern. Table 4 shows
descriptive statistics for all 4 PROMs procedures
and the 2 chronic conditions that we analyzed,
using the kmeans clusters. The mode refers to the
most frequently observed profile within the cluster
and its associated index score. Such simple descrip-
tive statistics give a far clearer picture of the distri-
bution of EQ-5D-3L index scores than are usually
reported. This table also demonstrates that the
mode is not the key feature of the groups or the best
descriptor of their distributions, suggesting that the
label bimodal should not be used.
To highlight further the contribution of weight-
ing, we reanalyzed the NHS PROMs data, applying
the value sets from different countries41 using a
standard algorithm.42 The results of this analysis
are in the online Appendix, which shows that the
2-groups-and-gap characteristic of EQ-5D-3L index
distributions is not uniquely associated with the
UK value set or with any technique for eliciting
weights. However, the index scores that define the
clusters differ between different value sets. This
also emphasizes that for any given set of patients’
EQ-5D-3L data, the value set used to summarize
profiles may strongly influence the results.
DISCUSSION
Nonnormal distributions of index-weighted EQ-
5D-3L data featuring 2 distinct groups of patients
are commonly observed. This has implications for
statistical analysis and modeling of those data. Our
analysis suggests that this pattern is a result of the
EQ-5D-3L classification system, which generates
differences between patients with the same condi-
tion in respect of dimensions that are mainly
observed at level 2 or 3. The weights commonly
used to calculate the index exacerbate this grouping
by placing a larger weight on level 3 observations,
generating a noticeable gap in index scores between
the groups.
A further factor is that in general, only a few of
the 243 potential EQ-5D-3L profiles are observed
Figure 6 Distribution of presurgery Oxford Hip Score for hip
replacement patients, identified by EQ-5D clusters.
Table 4 Distributions of EQ-5D Index for Six Conditions According to High and Low Clusters










Hip 0.019 20.003 20.160 (22232) 0.128 20.594 to 0.313 0.631 0.620 0.691 (21221) 0.087 0.329 to 0.883
Knee 0.052 0.055 0.159 (21231) 0.122 20.594 to 0.345 0.655 0.691 0.691 (21221) 0.084 0.362 to 0.883
Vein 0.130 0.159 0.088 (21232) 0.140 20.594 to 0.436 0.755 0.796 0.796 (11121) 0.064 0.487 to 0.883
Hernia 0.183 0.189 0.159 (21231) 0.147 20.594 to 0.452 0.755 0.796 0.796 (11121) 0.065 0.485 to 0.883
Angina 0.088 0.088 20.016 (22232) 0.144 20.594 to 0.383 0.692 0.691 0.620 (21222) 0.095 0.414 to 0.883
Asthma 0.086 0.088 0.088 (21232) 0.159 20.484 to 0.383 0.722 0.725 0.796 (11121) 0.093 0.414 to 0.883
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with any great frequency. In a large and diverse data
set, it was found that just 22 profiles covered 90%
of all health states observed, and 161 were not
found at all.2 One reason is that profiles that contain
very great differences in levels between dimensions
are rarely observed: for example, profiles having
four level 1 dimensions and one level 3. It is there-
fore reasonable that patients’ health states form
groupings for particular conditions, since we are
unlikely to observe extreme variations from a typi-
cal EQ-5D profile for a particular condition.
Our analysis was conducted on the EQ-5D-3L. A
5-level version is now available, the EQ-5D-5L,43
and it will be important to examine whether similar
issues apply to data that it generates, using methods
similar to those used here.
One recommendation is that when one is analyz-
ing EQ-5D data, it is very important and informative
to examine profiles as well as index scores. As we
have argued elsewhere,2,4 concentrating on the EQ-5D
index in effect obscures useful information about
health states and may even produce misleading infor-
mation. In this case, we found that examining profiles
enabled a better understanding of the distribution of
index scores, which will be useful for those wishing
to analyze those scores for comparison, inference, and
mapping between different health measures.
We have examined the EQ-5D, but our analytical
approach applies to any health status index that
uses the weighted profile approach. This includes
both generic and condition-specific measures and
also indexes calculated without explicit weights,
such as the OHS. It is arguable that a measure such
as the OHS is far more wasteful of useful informa-
tion than the EQ-5D index and that it positively
obscures important differences between patients.
There are potentially 244,140,625 (512) different
OHS profiles; the OHS was not devised to be able to
generate and analyze these, but they exist as a by-
product of the way that the OHS is constructed. Its
simple scoring system reduces this to 49 categories,
involving a huge information loss. The vast majority
of those profiles would never be observed, but it is
likely that far more would be observed than 49 and
that the differences between them would be of rele-
vance in assessing patients’ health.
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